Dietary Salt Intake for Heart Failure

Overseen By Maya Guglin, MD

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Maya Guglin, MD

Disqualifiers: Hypertension, End stage renal disease, Cardiogenic shock

Compensation: Varies

Number of Visits: Unknown

Duration: 30 days

500 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to understand if low sodium (cardiac) diet is indeed necessary for better health outcomes in patients who suffered heart failure. This study will investigate the association between sodium intake and risk for 30-day re-admission in Heart Failure (HF) patients.

Who Is on the Research Team?

Maya Guglin, MD

Principal Investigator

Rutgers University

Are You a Good Fit for This Trial?

Inclusion Criteria

I am over 18 years old.

I was hospitalized for heart failure within the last 24 hours.

Exclusion Criteria

I have high blood pressure over 150/90 mmHg.

I have end stage kidney disease and need regular dialysis.

I am experiencing cardiogenic shock.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants are assigned to either a normal salt diet (3-4 gm/day) or a cardiac diet (2 gm/day) to assess the impact on heart failure outcomes

30 days

Follow-up

Participants are monitored for 30-day readmission and other health outcomes after discharge

30 days

What Are the Treatments Tested in This Trial?

Interventions

• Cardiac Diet

How Is the Trial Designed?

Group I: Normal Salt Diet Experimental Treatment 1 Intervention

3-4 gm/day salt diet

Group II: Cardiac Diet Placebo Group 1 Intervention

2 gm/day salt diet

Who Is Running the Clinical Trial?

Maya Guglin, MD

Lead Sponsor